MINNEAPOLIS, June 06, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, today announced the extension of its pilot phase under its previously announced supply and collaboration agreement with DaVita Inc. (NYSE: DVA) until August 31, 2024. This program aims to pilot Aquadex® ultrafiltration therapy for adult patients suffering from congestive heart failure and related conditions in select U. ...

"We are pleased to be able to support DVA in this transition and are excited for this next chapter with Danielle and the entire team in Portland," remarked Radiant's Founder and CEO, Bohn Crain. "We have purposefully positioned ourselves to bring value to logistics entrepreneurs like Danielle and believe that the DVA transaction is representative of a broader pipeline of opportunities available to us in the marketplace. We have a particular interest in continuing to build density in markets like Portland, w ...

One stock to keep an eye on is DaVita (DVA) . DVA is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock is trading with a P/E ratio of 14.27, which compares to its industry's average of 21.27. DVA's Forward P/E has been as high as 15.37 and as low as 9.57, with a median of 13.62, all within the past year. Investors should also note that DVA holds a PEG ratio of 1.05. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's e ...

DaVita (DVA) witnessed strong momentum year to date. Shares of the company rallied 34.5% compared with 11.2% growth of the industry in the same time frame. The S&P 500 Composite has risen 11.7% during the same period. With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) company appears to be a solid wealth creator for its investors at the moment. Denver, CO-headquartered DaVita is a leading provider of dialysis services in the United States to patients suffering from chronic k ...

Madhu Narasimhan named to leadership role to accelerate technology-based innovations at DaVita DENVER, May 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that Madhu Narasimhan will assume the role of chief information officer (CIO), effective June 3, 2024. Madhu Narasimhan, DaVita CIO In this leadership position, Narasimhan will be responsible for accelerating the implementation of DaVita's industry-leading health technology platforms. She will oversee DaVit ...

The Driehaus strategy applies the “buy high and sell higher" theory, a successful investment approach that helped Richard Driehaus earn a place in Barron’s All-Century Team. The Driehaus strategy can be applied to choose the best momentum stocks.To that end, stocks like DaVita (DVA) , Minerals Technologies (MTX) , Alphabet (GOOGL) and Garmin (GRMN) have been selected as the momentum picks for the day using the Driehaus strategy.A Detailed Look Into the Driehaus StrategyRegarding the strategy, Driehaus once ...

DENVER, May 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on Tuesday, May 14th, 2024 at 5:00 pm Pacific Daylight Time. To view the live webcast, visit the BofA page and create a free registration. About DaVita Inc. DaVita (NYSE: DVA) is a health care provider focused on transformin ...

In the post-pandemic period, the Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare treatment. In the past few years, there has been a significant rise in demand for telemedicine-focused online medical and artificial intelligence (AI)-powered technology services. Post-pandemic, many healthcare companies that were traditionally not technology-based transformed to survive in the market. Per a report by Precedence Research, the global home health ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. DaVita HealthCare (DVA) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.DaVita HealthCare is one of 1050 individual stocks in the Medical sector. Collectively, these ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style Sco ...